BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McCaw TR, Inga E, Chen H, Jaskula-Sztul R, Dudeja V, Bibb JA, Ren B, Rose JB. Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance. Oncologist 2021;26:e608-21. [PMID: 33284507 DOI: 10.1002/onco.13627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Güner G, Aßfalg M, Zhao K, Dreyer T, Lahiri S, Lo Y, Slivinschi BI, Imhof A, Jocher G, Strohm L, Behrends C, Langosch D, Bronger H, Nimsky C, Bartsch JW, Riddell SR, Steiner H, Lichtenthaler SF. Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity. EMBO Mol Med 2022;:e16084. [PMID: 36069059 DOI: 10.15252/emmm.202216084] [Reference Citation Analysis]
2 Federman N. Molecular pathogenesis of desmoid tumor and the role of γ-secretase inhibition. NPJ Precis Oncol 2022;6:62. [PMID: 36068332 DOI: 10.1038/s41698-022-00308-1] [Reference Citation Analysis]
3 Chen H, Yu T, Lin L, Xing L, Cho SF, Wen K, Aardalen K, Oka A, Lam J, Daley M, Lu H, Munshi N, Anderson KC, Tai YT. γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation. Blood Cancer J 2022;12:118. [PMID: 35973981 DOI: 10.1038/s41408-022-00716-3] [Reference Citation Analysis]
4 Fragkiadakis M, Zingiridis M, Loukopoulos E, Neochoritis CG. New oxacycles on the block: benzodioxepinones via a Passerini reaction. Mol Divers 2022. [PMID: 35900638 DOI: 10.1007/s11030-022-10502-9] [Reference Citation Analysis]
5 Riedel RF, Agulnik M. Evolving strategies for management of desmoid tumor. Cancer 2022. [PMID: 35670122 DOI: 10.1002/cncr.34332] [Reference Citation Analysis]
6 Zhang E, Miller A, Clinton C, DeSmith K, Voss SD, Aster JC, Church AJ, Rahbar R, Eberhart N, Janeway KA, DuBois SG. Gamma Secretase Inhibition for a Child With Metastatic Glomus Tumor and Activated NOTCH1. JCO Precis Oncol 2022;6:e2200099. [PMID: 35731997 DOI: 10.1200/PO.22.00099] [Reference Citation Analysis]
7 Foglizzo V, Marchiò S. Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy. Cancers (Basel) 2022;14:2473. [PMID: 35626078 DOI: 10.3390/cancers14102473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Anobile DP, Montenovo G, Pecoraro C, Franczak M, Ait Iddouch W, Peters GJ, Riganti C, Giovannetti E. Splicing deregulation, microRNA and Notch aberrations: fighting the three-headed dog to overcome drug resistance in malignant mesothelioma. Expert Review of Clinical Pharmacology. [DOI: 10.1080/17512433.2022.2074835] [Reference Citation Analysis]
9 Chen WK, Oon CE, Kaur G, Sainson RC, Li J. Downregulation of Manic fringe impedes angiogenesis and cell migration of renal carcinoma. Microvascular Research 2022. [DOI: 10.1016/j.mvr.2022.104341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wen J, Liu D, Zhao L. Small molecules targeting γ-secretase and their potential biological applications. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kieran R, de Paula BHR, Hubank M, Barker A, Paterson AL, Gilligan D, Doherty GJ. Response of NOTCH1-Activated Tracheal Adenoid Cystic Carcinoma to the Gamma Secretase Inhibitor Nirogacestat. JCO Precis Oncol 2021;5:1579-83. [PMID: 34994644 DOI: 10.1200/PO.21.00228] [Reference Citation Analysis]
12 Sen S, Hallee L, Lam CK. The Potential of Gamma Secretase as a Therapeutic Target for Cardiac Diseases. J Pers Med 2021;11:1294. [PMID: 34945766 DOI: 10.3390/jpm11121294] [Reference Citation Analysis]
13 Bhattarai S, Devkota S, Wolfe MS. Design of Transmembrane Mimetic Structural Probes to Trap Different Stages of γ-Secretase-Substrate Interaction. J Med Chem 2021;64:15367-78. [PMID: 34647731 DOI: 10.1021/acs.jmedchem.1c01395] [Reference Citation Analysis]
14 González-Martínez S, Pérez-Mies B, Pizarro D, Caniego-Casas T, Cortés J, Palacios J. Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma. Int J Mol Sci 2021;22:7398. [PMID: 34299016 DOI: 10.3390/ijms22147398] [Reference Citation Analysis]
15 Muftuoglu Y, Pajonk F. Targeting Glioma Stem Cells. Neurosurg Clin N Am 2021;32:283-9. [PMID: 33781508 DOI: 10.1016/j.nec.2021.01.002] [Reference Citation Analysis]
16 Akil A, Gutiérrez-García AK, Guenter R, Rose JB, Beck AW, Chen H, Ren B. Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective. Front Cell Dev Biol 2021;9:642352. [PMID: 33681228 DOI: 10.3389/fcell.2021.642352] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]